Literature DB >> 22836745

Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections.

Yasser Madani1, Bhupinder Mann.   

Abstract

Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs). Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal. Knowledge of such potential adverse effects is essential to enable early recognition and withdrawal of the drug. Patients on long-term nitrofurantoin should be reviewed and monitored regularly. Management involves early consideration of the condition, and prompt withdrawal of the drug. We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836745      PMCID: PMC6547957          DOI: 10.4104/pcrj.2012.00059

Source DB:  PubMed          Journal:  Prim Care Respir J        ISSN: 1471-4418


  10 in total

Review 1.  The etiology and management of recurrent urinary tract infections in postmenopausal women.

Authors:  Carrie Jung; Linda Brubaker
Journal:  Climacteric       Date:  2019-01-09       Impact factor: 3.005

Review 2.  Recurrent urinary tract infections in women.

Authors:  Abdullatif Aydin; Kamran Ahmed; Iftikhar Zaman; Muhammad Shamim Khan; Prokar Dasgupta
Journal:  Int Urogynecol J       Date:  2014-11-20       Impact factor: 2.894

3.  Recurrent nitrofurantoin-induced giant cell interstitial pneumonia: Case report and literature review.

Authors:  Boeun Lee; Arvind Balavenkataraman; Devang Sanghavi; Kristin Walter
Journal:  Respir Med Case Rep       Date:  2015-01-29

4.  Unrecognized Interstitial Lung Disease as a Result of Chronic Nitrofurantoin Use.

Authors:  Kerry Anne Rambaran; Charles F Seifert
Journal:  Drug Saf Case Rep       Date:  2016-12

5.  An Explainable Supervised Machine Learning Model for Predicting Respiratory Toxicity of Chemicals Using Optimal Molecular Descriptors.

Authors:  Keerthana Jaganathan; Hilal Tayara; Kil To Chong
Journal:  Pharmaceutics       Date:  2022-04-11       Impact factor: 6.525

6.  Awareness towards the main ILD among primary care physicians.

Authors:  Mariana Silva; Amélia Fernandes; Ana Rita Pereira; Sofia Madanelo; Tatiana Clemêncio; Pedro Gonçalo Ferreira
Journal:  Multidiscip Respir Med       Date:  2022-04-26

7.  Long-term nitrofurantoin: an analysis of complication awareness, monitoring, and pulmonary injury cases.

Authors:  Toby Peter Speirs; Nicole Tuffin; Finlay Mundy-Baird; Helena Sakota; Sarah Mulholland; Michelle Westlake; Max Lyon; Andrew R Medford; Charles Sharp; Michael Darby; Mahableshwar Albur; Francis Keeley; Helena Burden; Charlie Kenward; Elizabeth Jonas; Shaney Barratt; Huzaifa I Adamali
Journal:  BJGP Open       Date:  2021-12-14

8.  Acute pulmonary function decline and radiographic abnormalities: chronic cause?

Authors:  Kathleen M Capaccione; Clement V Tran; Jay S Leb; Mary M Salvatore; Belinda D'souza
Journal:  Breathe (Sheff)       Date:  2021-03

Review 9.  Diagnosis and management of recurrent urinary tract infections in non-pregnant women.

Authors:  Kalpana Gupta; Barbara W Trautner
Journal:  BMJ       Date:  2013-05-29

10.  Reversible lung fibrosis in a 6-year-old girl after long term nitrofurantoin treatment.

Authors:  Lise Fischer Mikkelsen; Sune Rubak
Journal:  BMC Pulm Med       Date:  2020-11-26       Impact factor: 3.317

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.